The multi-factorial nature of clinical multidrug resistance in cancer

YG Assaraf, A Brozovic, AC Gonçalves… - Drug resistance …, 2019 - Elsevier
Curative cancer therapy remains a major challenge particularly in cancers displaying
multidrug resistance (MDR). The MDR phenotype is characterized by cross-resistance to a …

Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence

SR Lin, CH Chang, CF Hsu, MJ Tsai… - British journal of …, 2020 - Wiley Online Library
Traditional chemotherapy is being considered due to hindrances caused by systemic
toxicity. Currently, the administration of multiple chemotherapeutic drugs with different …

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

L Merkens, V Sailer, D Lessel, E Janzen… - Journal of Experimental …, 2022 - Springer
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …

Metabolic regulation of homologous recombination repair by MRE11 lactylation

Y Chen, J Wu, L Zhai, T Zhang, H Yin, H Gao, F Zhao… - Cell, 2024 - cell.com
Lactylation is a lactate-induced post-translational modification best known for its roles in
epigenetic regulation. Herein, we demonstrate that MRE11, a crucial homologous …

Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles

A Liskova, M Samec, L Koklesova, A Brockmueller… - Epma Journal, 2021 - Springer
Cost-efficacy of currently applied treatments is an issue in overall cancer management
challenging healthcare and causing tremendous economic burden to societies around the …

Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance

MH Vasconcelos, HR Caires, A Ābols… - Drug Resistance …, 2019 - Elsevier
Cancer-derived extracellular vesicles (EVs) have been detected in the bloodstream and
other biofluids of cancer patients. They carry various tumor-derived molecules such as …

DNA repair in cancer initiation, progression, and therapy—a double-edged sword

K Kiwerska, K Szyfter - Journal of applied genetics, 2019 - Springer
Genomic and mitochondrial DNA molecules are exposed continuously for a damaging
activity of chemical, physical, and internal genotoxicants. When DNA repair machinery is not …

The post-chemotherapy changes of tumor physical microenvironment: targeting extracellular matrix to address chemoresistance

Y Li, G Jin, N Liu, H Guo, F Xu - Cancer Letters, 2024 - Elsevier
The tumor physical microenvironment (TPME) contributes to cancer chemoresistance in both
mechanical and mechanobiological approaches. Along with chemotherapy, the tumor …

Metformin for cardiovascular protection, inflammatory bowel disease, osteoporosis, periodontitis, polycystic ovarian syndrome, neurodegeneration, cancer …

M Ala, M Ala - ACS pharmacology & translational science, 2021 - ACS Publications
Diabetes is accompanied by several complications. Higher prevalence of cancers,
cardiovascular diseases, chronic kidney disease (CKD), obesity, osteoporosis, and …

Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours

YFI Setargew, K Wyllie, RD Grant, JL Chitty, TR Cox - Cancers, 2021 - mdpi.com
Simple Summary To improve efficacy of solid cancer treatment, efforts have shifted towards
targeting both the cancer cells and the surrounding tumour tissue they grow in. The lysyl …